MIF in autoimmunity and novel therapeutic approaches

Cvetkovic, 2006, Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders, Int Immunopharmacol, 6, 1527, 10.1016/j.intimp.2006.06.009 Hoi, 2006, Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice, J Immunol, 177, 5687, 10.4049/jimmunol.177.8.5687 Foote, 2004, Macrophage migration inhibitory factor in systemic lupus erythematosus, J Rheumatol, 31, 268 Sánchez, 2006, Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus, Genes Immun, 7, 433, 10.1038/sj.gene.6364310 Niino, 2000, Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet's disease, J Neurol Sci, 179, 127, 10.1016/S0022-510X(00)00397-X Ohwatari, 2001, Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis, Ann Otol Rhinol Laryngol, 110, 1035, 10.1177/000348940111001108 Becker, 2006, Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides, Clin Rheumatol, 25, 368, 10.1007/s10067-005-0045-9 Amoli, 2002, Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum, J Rheumatol, 29, 1671 Bojunga, 2003, Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice, Cytokine, 21, 179, 10.1016/S1043-4666(03)00076-0 Cvetkovic, 2005, Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes, Endocrinology, 146, 2942, 10.1210/en.2004-1393 Stosic-Grujicic, 2007, Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus, J Cell Physiol, 9999, 1 Santos, 2001, Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids, Clin Exp Immunol, 123, 309, 10.1046/j.1365-2249.2001.01423.x Leech, 2003, Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis, Arthritis Rheum, 48, 1881, 10.1002/art.11165 Ichiyama, 2004, Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF), Cytokine, 26, 187, 10.1016/j.cyto.2004.02.007 Santos, 2008, Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation, Clin Exp Immunol, 152, 372, 10.1111/j.1365-2249.2008.03639.x Kim, 2007, Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis, J Rheumatol, 34, 927 Onodera, 2000, Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis, J Biol Chem, 274, 444, 10.1074/jbc.275.1.444 Worthington, 2005, Investigating the genetic basis of susceptibility to rheumatoid arthritis, J Autoimmun, 25, 16, 10.1016/j.jaut.2005.09.011 Radstake, 2005, Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor, Arthritis Rheum, 52, 3020, 10.1002/art.21285 Baker, 1991, Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis, Cell Immunol, 134, 505, 10.1016/0008-8749(91)90321-2 Denkinger, 2003, In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system, J Immunol, 170, 1274, 10.4049/jimmunol.170.3.1274 Powell, 2005, Macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis, J Immunol, 175, 5611, 10.4049/jimmunol.175.9.5611 Nicoletti, 2005, Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain–Barre syndrome and experimental allergic neuritis, J Neuroimmunol, 168, 168, 10.1016/j.jneuroim.2005.07.019 Murakami, 2001, Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance, Eur J Clin Investig, 31, 337, 10.1046/j.1365-2362.2001.00796.x Dambacher, 2007, Macrophage migration inhibitory factor (MIF)-173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease, Inflamm Bowel Dis, 13, 71, 10.1002/ibd.20008 Matsui, 2004, Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis, J Mol Cell Cardiol, 37, 557, 10.1016/j.yjmcc.2004.05.016 Yang, 1998, Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production, Mol Med, 4, 413, 10.1007/BF03401748 Lan, 2000, Expression of macrophage migration inhibitory factor in human glomerulonephritis, Kidney Int, 57, 499, 10.1046/j.1523-1755.2000.00869.x Berdeli, 2005, Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome, Pediatr Nephrol, 20, 1566, 10.1007/s00467-005-1930-9 Nakajima, 2006, Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury, Liver Int, 26, 346, 10.1111/j.1478-3231.2005.01216.x Shimizu, 2001, High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis, J Invest Dermatol, 116, 989, 10.1046/j.0022-202x.2001.01366.x Donn, 2004, Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis, J Invest Dermatol, 123, 484, 10.1111/j.0022-202X.2004.23314.x Tincani, 2007, Inflammatory molecules: a target for treatment of systemic autoimmune diseases, Autoimmun Rev, 7, 1, 10.1016/j.autrev.2007.03.001 Onodera, 2007, A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis, Arthritis Rheum, 56, 521, 10.1002/art.22407 Gregory, 2004, Reduced leukocyte–endothelial cell interaction in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice, Arthritis Rheum, 50, 3023, 10.1002/art.20470 Toh, 2006, Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor, J Immunol, 177, 4818, 10.4049/jimmunol.177.7.4818 Dios, 2002, Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity, J Med Chem, 45, 2410, 10.1021/jm010534q Senter, 2002, Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites, PNAS, 99, 141, 10.1073/pnas.011569399 Cheng, 2006, Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity, Bioorg Med Chem Lett, 16, 3376, 10.1016/j.bmcl.2006.04.038 Crichlow, 2007, Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor, J Biol Chem, 282, 23089, 10.1074/jbc.M701825200